Ashley Foster
Acute Care · Richmond, VANPI 1245548718
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 43.9% of the total. Reporting peaked in 2021 at $965 and has fallen 66.4% since, to $325 in 2025.
Across 97 payments — averaging $26.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Gilead$249
- Abbott$179
- Fujifilm Healthcare Americas Corporation$147
- Scpharmaceuticals Inc.$121
- Boehringer Ingelheim$110
- plus $631 from 13 others
What the payments were for
- Food & beverage$2,562100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 54 | $1,125 |
| Gilead | 10 | $249 |
| Abbott | 8 | $179 |
| Fujifilm Healthcare Americas Corporation | 2 | $147 |
| Scpharmaceuticals Inc. | 1 | $121 |
| Boehringer Ingelheim | 1 | $110 |
| Genentech USA, Inc. | 1 | $101 |
| Exelixis Inc. | 1 | $100 |
| Eisai Inc. | 5 | $98 |
| AbbVie | 4 | $73 |
| Sanofi | 1 | $65 |
| Intra-sana Laboratories | 1 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $29 |
| Novo Nordisk | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| W. L. Gore & Associates, Inc. | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,562 in reported general payments places this provider in the 85th percentile of 599 acute care providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 13 | $203 |
Paid to pharmacies, not to this prescriber.
Other acute care in Richmond
- Rachel DukeRichmond$751K
- Mica FerlisRichmond$20K
- Jonathan PenderRichmond$13K
- Erin PerlmutterRichmond$13K
- Emily GilbertRichmond$10K
- Linda HazelgrenRichmond$9K
- Stephanie HerndonRichmond$9K
- Christine RobinsonRichmond$8K
- Kelly McAdamsRichmond$7K
- Linda KashiwabaraRichmond$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.